Transition Metal Catalyzed Synthesis of NEP Inhibitor Intermediates

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current processes for producing NEP inhibitors, such as N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid or its ester, are not economically viable for large-scale manufacture and lack efficient alternative routes for intermediates.

Innovation Solution

A new process involving the conversion of a compound of formula (1) into a compound of formula (3) using a transition metal catalyst, optionally with a base, to produce NEP inhibitors or their prodrugs, specifically utilizing palladium or other transition metals like Ruthenium, Rhodium, or Platinum as catalysts.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional processes are used for producing NEP inhibitors, then the synthesis can be performed with existing methods, but the process is not economically viable for large-scale manufacture and lacks efficiency

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoideconomic viability
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent changes the reaction parameters by using transition metal catalysts (palladium, ruthenium, rhodium, or platinum) instead of conventional catalysts, and by optimizing the base selection (carbonates, bicarbonates, hydroxides, or amine bases). These parameter changes improve diastereoselectivity and synthesis efficiency, making the process economically viable for large-scale manufacture while maintaining ease of manufacture through well-established catalytic chemistry

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If alternative routes are developed for preparing intermediates, then synthesis efficiency and diastereoselectivity are improved, but the process complexity increases

Engineering Contradiction:
ImprovediastereoselectivityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent introduces transition metal catalysts as intermediaries to mediate the conversion of compound (1) to compound (3). The catalyst system (palladium, ruthenium, rhodium, or platinum with appropriate ligands) acts as a mediator that enables high diastereoselectivity through controlled catalytic cycles. The base serves as another intermediary to facilitate the reaction. This intermediary approach improves manufacturing precision without requiring complex process equipment, thereby limiting the increase in device complexity

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process provides an economically advantageous alternative for large-scale production of NEP inhibitors by improving the synthesis efficiency and diastereoselectivity, making it suitable for pharmaceutical manufacturing.

Implementation Method 1

reacting a compound of formula (1) with a transition metal catalyst, optionally in the presence of a base, to obtain the compound of formula (3)

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentEP2609075B1Process for the preparation of intermediates for the manufacture of NEP inhibitors
Publication Date: 2016.03.16 NOVARTIS AG
  • EP2609075B1 patent drawing
  • EP2609075B1 patent drawing
  • EP2609075B1 patent drawing

AI summary

The invention relates to a new process for producing useful intermediates for the manufacture of NEP inhibitors or prodrugs thereof, in particular NEP inhibitors comprising a y-amino-5-biphenyl-a-methylalkanoic acid, or acid ester, backbone, such as N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester or salt thereof.